Betaseron: a breakthrough treatment for multiple sclerosis

Multiple sclerosis (MS) is the most common cause of disability in young adults; in Canada, it affects 1 in 1,000 people. A chronic and complicated demyelinating autoimmune disorder of the central nervous system, MS has no known cure. Indeed, there has been no effective treatment until recently.